Compare Dr. Reddys with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs LAURUS LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB LAURUS LABS DR. REDDYS LAB/
LAURUS LABS
 
P/E (TTM) x 48.0 31.6 151.6% View Chart
P/BV x 4.6 12.9 35.8% View Chart
Dividend Yield % 0.5 0.3 160.2%  

Financials

 DR. REDDYS LAB   LAURUS LABS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-21
LAURUS LABS
Mar-21
DR. REDDYS LAB/
LAURUS LABS
5-Yr Chart
Click to enlarge
High Rs5,515386 1,429.4%   
Low Rs3,02864 4,757.3%   
Sales per share (Unadj.) Rs1,145.489.7 1,276.8%  
Earnings per share (Unadj.) Rs114.518.3 624.3%  
Cash flow per share (Unadj.) Rs188.422.2 850.1%  
Dividends per share (Unadj.) Rs25.002.00 1,250.0%  
Avg Dividend yield %0.60.9 65.8%  
Book value per share (Unadj.) Rs1,053.248.3 2,179.9%  
Shares outstanding (eoy) m166.30536.60 31.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.72.5 148.9%   
Avg P/E ratio x37.312.3 304.4%  
P/CF ratio (eoy) x22.710.1 223.6%  
Price / Book Value ratio x4.14.7 87.2%  
Dividend payout %21.810.9 200.2%   
Avg Mkt Cap Rs m710,289120,585 589.0%   
No. of employees `000NANA-   
Total wages/salary Rs m36,2993,970 914.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m190,47548,135 395.7%  
Other income Rs m2,914237 1,231.6%   
Total revenues Rs m193,38948,372 399.8%   
Gross profit Rs m38,69915,507 249.6%  
Depreciation Rs m12,2882,051 599.2%   
Interest Rs m970682 142.3%   
Profit before tax Rs m28,35513,011 217.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3193,173 293.7%   
Profit after tax Rs m19,0369,838 193.5%  
Gross profit margin %20.332.2 63.1%  
Effective tax rate %32.924.4 134.8%   
Net profit margin %10.020.4 48.9%  
BALANCE SHEET DATA
Current assets Rs m145,50330,749 473.2%   
Current liabilities Rs m81,03824,572 329.8%   
Net working cap to sales %33.812.8 263.7%  
Current ratio x1.81.3 143.5%  
Inventory Days Days6111 565.6%  
Debtors Days Days9510 960.5%  
Net fixed assets Rs m109,97926,758 411.0%   
Share capital Rs m8321,073 77.5%   
"Free" reserves Rs m174,31924,853 701.4%   
Net worth Rs m175,15125,926 675.6%   
Long term debt Rs m6,2994,292 146.8%   
Total assets Rs m255,48257,507 444.3%  
Interest coverage x30.220.1 150.5%   
Debt to equity ratio x00.2 21.7%  
Sales to assets ratio x0.70.8 89.1%   
Return on assets %7.818.3 42.8%  
Return on equity %10.937.9 28.6%  
Return on capital %16.245.3 35.7%  
Exports to sales %51.30-   
Imports to sales %18.134.4 52.5%   
Exports (fob) Rs m97,699NA-   
Imports (cif) Rs m34,42016,560 207.9%   
Fx inflow Rs m97,69933,250 293.8%   
Fx outflow Rs m34,42016,560 207.9%   
Net fx Rs m63,27916,690 379.1%   
CASH FLOW
From Operations Rs m35,7037,330 487.1%  
From Investments Rs m-22,660-9,410 240.8%  
From Financial Activity Rs m-2982,547 -11.7%  
Net Cashflow Rs m12,858468 2,749.2%  

Share Holding

Indian Promoters % 26.7 27.3 97.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.0 25.7 171.2%  
FIIs % 29.3 21.5 136.4%  
ADR/GDR % 14.0 0.0 -  
Free float % 59.2 72.7 81.5%  
Shareholders   131,498 299,257 43.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   ZENOTECH LABS  ISTREET NETWORK  KWALITY PHARMA  UNICHEM LAB  GENNEX LAB.  



Today's Market

Indian Indices End Flat; Nestle, HDFC and ICICI Bank Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

LAURUS LABS Announces Quarterly Results (1QFY22); Net Profit Up 40.7% (Quarterly Result Update)

Jul 31, 2021 | Updated on Jul 31, 2021

For the quarter ended June 2021, LAURUS LABS has posted a net profit of Rs 2 bn (up 40.7% YoY). Sales on the other hand came in at Rs 13 bn (up 31.2% YoY). Read on for a complete analysis of LAURUS LABS 's quarterly results.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Sep 22, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - NORRIS MEDICINES COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS